UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047982
Receipt number R000054104
Scientific Title Evaluation of urinary function and quality of life in patients who undergo retzius-sparing robot-assisted radical prostatectomy
Date of disclosure of the study information 2022/06/10
Last modified on 2024/12/09 13:23:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of urinary function and quality of life in patients who undergo retzius-sparing robot-assisted radical prostatectomy

Acronym

Evaluation of urinary function and quality of life in patients who undergo retzius-sparing robot-assisted radical prostatectomy

Scientific Title

Evaluation of urinary function and quality of life in patients who undergo retzius-sparing robot-assisted radical prostatectomy

Scientific Title:Acronym

Evaluation of urinary function and quality of life in patients who undergo retzius-sparing robot-assisted radical prostatectomy

Region

Japan


Condition

Condition

prostate cancer

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of oncological outcome, quality of life, and urinary function in patients who undergo retzius-sparing robot-assisted radical prostatectomy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Functional outcome in patients who undergo retzius-sparing robot-assisted radical prostatectomy 6 months after prostatectomy

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1, Patients whose informed consent is obtained
2, > 20 years old
3, patients classified as low or intermediate risk in NCCN risk classification
4, patients who undergo retzius-sparing robot-assisted radical prostatectomy

Key exclusion criteria

1, uncompleted retzius-sparing robot-assisted radical prostatectomy
2, patients who are judged as unsuitable for the present study by investigator

Target sample size

110


Research contact person

Name of lead principal investigator

1st name Yasushi
Middle name
Last name Nakai

Organization

Nara Medical University

Division name

Department of Urology

Zip code

634-8521

Address

840 Shijyocho, Kashihara, Nara, Japan

TEL

0744223051

Email

nakaiyasusiuro@live.jp


Public contact

Name of contact person

1st name Yasushi
Middle name
Last name Nakai

Organization

Nara Medical University

Division name

Urology

Zip code

634-8521

Address

840 Shijyocho, Kashihara, Nara, Japan

TEL

0744223051

Homepage URL


Email

nakaiyasusiuro@live.jp


Sponsor or person

Institute

Nara Medical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nara Medical University

Address

840 Shijyocho, Kashihara, Nara, Japan

Tel

0744223051

Email

ino_rinri@naramed-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 06 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 04 Month 16 Day

Date of IRB

2020 Year 06 Month 26 Day

Anticipated trial start date

2020 Year 06 Month 27 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

evaluation of urinary function, quality of life, oncological outcome


Management information

Registered date

2022 Year 06 Month 08 Day

Last modified on

2024 Year 12 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054104